Time management in radiation oncology: Evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer: The DEGRO-QUIRO trial

Strahlentherapie und Onkologie

Volumn 190, Issue 1, 2014, Pages 17-25

  Keilholz, L ^a   Willner, J ^a   Thiel, H J ^b   Zamboglou, N ^c   Sack, H ^d   Popp, W ^e  

^a INSTITUTE OF PATHOLOGY   (Germany)

^b Abteilung für Radioonkologie   (Germany)

^c Klinikum Offenbach GmbH   (Germany)

^d Deutsche Gesellschaft fur Chirurgie   (Germany)

^e Prime Networks AG   (Switzerland)

Author keywords

Conformal; Health care; Intensity modulated; Prostate neoplasms; Quality assurance; Radiotherapy; Task performance and analysis

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MEDICAL SPECIALIST; MEDICAL STAFF; PHYSICIAN; PROSPECTIVE STUDY; PROSTATE CANCER; RADIOLOGICAL TECHNOLOGIST; RADIOTHERAPY PLANNING SYSTEM; TIME MANAGEMENT;

GERMANY; HUMANS; MALE; MEDICAL STAFF; PREVALENCE; PROSTATIC NEOPLASMS; RADIATION ONCOLOGY; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, IMAGE-GUIDED; TIME AND MOTION STUDIES; TIME MANAGEMENT; UTILIZATION REVIEW; WORKLOAD;

EID: 84891553022     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0440-0     Document Type: Article

References (19)

1. Bentzen SM, Herren G, Cottier B et al (2005) Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. Radiother Oncol 75:355-369
2. Blank E, Willich N, Fietkau R et al (2012) Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial. Strahlenther Onkol 188:113-119
3. Budach W, Bölke E, Fietkau R et al (2011) Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients. The DEGRO-QUIRO trial. Strahlenther Onkol 187:449-460
4. Davis BJ, Horwitz EM, Lee WR et al (2012) American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. Brachytherapy 11:6-19
5. Dolezel M, Odrazka K, Vaculikova M et al (2010) Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy. Strahlenther Onkol 186:197-202
6. Fietkau R, Budach W, Zamboglou N et al (2012) Time management in radiation oncology: development and evaluation of a modular system based on the example of rectal cancer treatment. The DEGRO-QUIRO trial. Strahlenther Onkol 188:5-11
7. Hentschel B, Oehler W, Strauß D et al (2011) Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer. Strahlenther Onkol 187:183-190
8. Horwich A, Hugosson J, Reijke T de et al (2013) Prostate cancer: ESMO Consensus Conference Guidelines 2012. Ann Oncol 24:1141-1162
9. Leitlinienprogramm Onkologie der AWMW, Deutschen Krebsgesellschaft e. V. und Deutschen Krebshilfe e. V. (eds) (2011) S3-Leitlinie zum Prostatakarzinom, 2011; Version 2.0, Sept. 2011. Berlin
10. Matzinger O, Duclos F, Bergh A van den et al (2009) Acute toxicity of curative radiotherapy for intermediate- and high-risk localized prostate cancer in the EORTC trial 22991. Eur J Cancer 45:2825-2834
11. Nguyen PL, Gu X, Lipsitz SR et al (2011) Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol 29:1517-1524
12. Perna L, Fiorino C, Cozzarini C et al (2009) Sparing the penile bulb in the radical irradiation of clinically localized prostate carcinoma: a comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and helical tomotherapy. Radiother Oncol 93:57-63
13. Resnick MJ, Koyama T, Kang-Hsien F et al (2013) Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 368:436-445
14. Robert Koch-Institut und Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (eds) (2012) Krebs in Deutschland 2007/2008, 8. überarbeitete und aktualisierte Herausgabe, Robert Koch Institut 2012, Bibliographische Information der Deutschen Bibliothek; Berlin
15. Tzikas A, Karaiskos P, Papanikolaou N et al (2011) Investigating the clinical aspects of using CT vs CT-MRI images during organ delineation and treatment planning in prostate cancer. Technol Cancer Res Treat 10:231-242
16. Slotman BJ, Cottier B, Bentzen SM et al (2005) Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1. Radiother Oncol 75:349-354
17. Wolff D, Stieler F, Welzel G et al (2009) Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 93:226-233
18. Zabel-du Bois A, Milker-Zabel S, Henzel M et al (2012) Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery. QUIRO-DEGRO trial. Strahlenther Onkol 188:769-776
19. Zelefsky MJ, Levin EJ, Hunt M et al (2008) Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70:1124-1129